INmune Bio Inc. INMB
1.42 USD +0.04 +2.90%
As of Nov 3, 10:57 AM ET
- Open
- 1.40
- Prev close
- 1.38
- Mkt cap
- 43.96M
- Vol
- 80.58K
- Avg vol
- 330.47K
- EPS
- -0.67
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.38
- High
- 1.42
- Forward P/E
- -2.23
- Beta
- 1.85
- Short ratio
- 18.08
- Inst. own
- 24.32%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 1, 2024
- 50-d avg
- 5.27
- 200-d avg
- 7.78
- 1y target
- 19.83
MAX chart
Chart tools
Chart is warming up
The all-time price history for INMB has not been loaded yet. Try again in a moment.
Altman Z-Score
-9.17 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 3
P/E -0.8×
P/S 829×
P/B 1.8×
P/FCF -1.8×
EV/EBITDA -0.4×
EV/Sales 355×
FCF Yield -57.0%
Gross Margin 100.0%
Operating Margin -61738.0%
Net Margin -91866.0%
ROE -195.3%
ROIC -125.7%
ROA -142.0%
Revenue 257.1%
Operating Income 27.6%
EPS (diluted) 11.8%
Free Cash Flow 29.2%
Current Ratio 3.6×
Quick Ratio 3.6×
Debt / Equity 0.0×
Net Debt / EBITDA 0.5×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31